Loading...
Avanos Medical, Inc.
AVNS•NYSE
Healthcare
Medical - Devices
$12.01
$0.13(1.09%)
Avanos Medical, Inc. (AVNS) Financial Performance & Income Statement Overview
Review Avanos Medical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.15%
↑ 2.15%
Operating Income Growth
-9533.33%
↓ 9533.33%
Net Income Growth
-534.47%
↓ 534.47%
Operating Cash Flow Growth
210.80%
↑ 210.80%
Operating Margin
-55.15%
↓ 55.15%
Gross Margin
54.60%
↑ 54.60%
Net Profit Margin
-55.80%
↓ 55.80%
ROE
-37.34%
↓ 37.34%
ROIC
-39.16%
↓ 39.16%
Avanos Medical, Inc. (AVNS) Income Statement & Financial Overview
Review Avanos Medical, Inc.'s (AVNS) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $179.60M | $170.40M | $171.70M | $166.10M |
Cost of Revenue | $81.60M | $77.50M | $76.10M | $71.30M |
Gross Profit | $98.00M | $92.90M | $95.60M | $94.80M |
Gross Profit Ratio | $0.55 | $0.55 | $0.56 | $0.57 |
R&D Expenses | $5.70M | $7.20M | $6.30M | $7.00M |
SG&A Expenses | $79.70M | $74.30M | $73.20M | $80.40M |
Operating Expenses | $516.50M | $76.20M | $79.50M | $87.40M |
Total Costs & Expenses | $598.10M | $153.70M | $155.60M | $158.70M |
Interest Income | $800000.00 | $700000.00 | $3.00M | $600000.00 |
Interest Expense | $2.80M | $3.20M | $3.10M | $3.10M |
Depreciation & Amortization | $11.10M | $11.70M | $11.30M | $11.40M |
EBITDA | -$406.60M | $24.40M | $23.00M | $18.90M |
EBITDA Ratio | -$2.26 | $0.14 | $0.13 | $0.11 |
Operating Income | -$418.50M | $12.00M | $16.10M | $7.40M |
Operating Income Ratio | -$2.33 | $0.07 | $0.09 | $0.04 |
Other Income/Expenses (Net) | -$2.00M | -$2.50M | -$100000.00 | -$2.50M |
Income Before Tax | -$420.50M | $9.50M | $6.20M | $1.50M |
Income Before Tax Ratio | -$2.34 | $0.06 | $0.04 | $0.009 |
Income Tax Expense | -$23.50M | $3.60M | $1.90M | $1.00M |
Net Income | -$397.30M | $4.30M | $1.80M | -$900000.00 |
Net Income Ratio | -$2.21 | $0.03 | $0.01 | -$0.005 |
EPS | -$8.64 | $0.09 | $0.04 | -$0.02 |
Diluted EPS | -$8.64 | $0.09 | $0.04 | -$0.02 |
Weighted Avg Shares Outstanding | $46.00M | $46.00M | $45.90M | $46.20M |
Weighted Avg Shares Outstanding (Diluted) | $46.00M | $46.60M | $46.30M | $46.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan